TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock ...

TORONTO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock ...

A UCLA-led team has developed a machine-learning model that can predict with a high degree of accuracy the short-term survival of dialysis patients on Continuous Renal Replacement Therapy (CRRT). CRRT ...

The work group aimed to make recommendations to clarify the processes for prescribing and preparing CRRT solutions based on the medication error data collected by the ...

Dartmouth Health member hospital Cheshire Medical Center introduced continuous renal replacement therapy (CRRT), a form of 24-hour dialysis, to its intensive care unit in the last year. The new ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received Emergency Use Authorizations (EUAs) from the U.S. Food and Drug ...

The Continuous Renal Replacement Therapy Market represents a critical segment within the global healthcare industry, specifically designed to provide life-saving treatment for patients experiencing ...

Baxter International Inc. BAX recently received Emergency Use Authorization (EUA) from the FDA for Regiocit, which is the only authorized citrate-based replacement solution available in the United ...

Only authorized citrate-based replacement solution available in the U.S. for use in continuous renal replacement therapy (CRRT) during COVID-19 pandemic Supports need for regional citrate ...

Only authorized citrate-based replacement solution available in the U.S. for use in continuous renal replacement therapy (CRRT) during COVID-19 pandemic Supports need for regional citrate ...